Raffaele Colasanto

Raffaele Colasanto has a diverse work experience in the pharmaceutical and scientific fields. Raffaele is currently working as the Head of Medical Affairs Oncology at Merck Group since May 2022. Prior to this, they held the role of Senior Medical Advisor Oncology at Merck Group from September 2021 to May 2022, where they were responsible for immuno-oncology launch indications and served as a scientific expert in oncology and immuno-oncology for various types of cancer. Raffaele also contributed to launch/brand strategies, provided internal training, and supported medical science liaisons (MSLs).

From 2018 to 2021, Raffaele worked as a Medical Advisor Oncology at Merck Group, again focusing on immuno-oncology launch indications and serving as a scientific expert across multiple cancer types. Additionally, they were responsible for key medical projects, including clinical trials, and contributed to launch/brand strategies while providing support to MSLs.

Before their roles at Merck Group, Raffaele gained experience at Bristol-Myers Squibb as an Associate Marketing Internship from August 2013 to January 2014. Raffaele was involved in marketing activities during this period.

Raffaele also has scientific research experience. Raffaele worked as a Research Scientist at Agrolabo S.p.A. from December 2009 to January 2013, where they led a European project focused on developing a diagnostic platform for mycotoxin detection. Raffaele also contributed to product development and pre-marketing analysis for a rapid test device, collaborating with other companies and universities.

Earlier in their career, Raffaele had research fellow positions at Institut für Mikrotechnik Mainz GmbH and the University of Turin - Analytical Chemistry Department in 2010 and 2009 respectively.

Furthermore, they worked as a Laboratory Analyst at Bioleader s.n.c., rete BiolaB for a brief period in 2008, performing chemical and microbiological analysis on food and environmental samples and conducting health inspections.

Overall, Raffaele Colasanto's work experience encompasses various roles in medical affairs, marketing, and scientific research, mainly in the pharmaceutical industry.

Raffaele Colasanto completed their education at the following institutions. From 2004 to 2009, they studied Industrial Biotechnologies and obtained a Master's degree from the Università degli Studi di Torino. Additionally, from 2013 to 2014, they pursued a Post Graduation Master's degree in Biomedical Product Management with a focus on PROBIOMED at LUISS Business School. Raffaele Colasanto also holds two additional certifications - "An Introduction to Operations Management" which was obtained in June 2013, and a "Digital Training Certificate" from Merck Group, although the details about the institution and the year of obtaining this certificate is not provided.